Daiichi Sankyo (OTCMKTS:DSNKY) Releases Earnings Results

Daiichi Sankyo (OTCMKTS:DSNKYGet Free Report) announced its quarterly earnings results on Friday. The company reported $0.22 earnings per share (EPS) for the quarter, Zacks reports. Daiichi Sankyo updated its FY 2024 guidance to 0.840-0.840 EPS.

Daiichi Sankyo Stock Down 2.5 %

Shares of DSNKY stock opened at $27.94 on Friday. The company has a 50 day simple moving average of $28.49 and a two-hundred day simple moving average of $32.99. Daiichi Sankyo has a 12 month low of $25.11 and a 12 month high of $42.48.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

See Also

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.